Whistleblower News: Medically Unnecessary Medical Equipment In $8.8M Health Care Fraud Scheme, Bank Of America's Merrill Lynch To Pay $15.2M To Mutual Fund Customers, $2.8M To Settle False Claims Act Allegations

Woman Indicted for Prescribing Medically Unnecessary Medical Equipment in $8.8 Million Health Care Fraud Scheme


A Georgia woman was arrested yesterday in Hampton, Georgia, on criminal charges related to her alleged scheme to defraud Medicare by prescribing medically unnecessary durable medical equipment (DME), which was then billed to Medicare. read more »

Bank of America's Merrill Lynch to pay $15.2 mln to mutual fund customers


Bank of America Corp's (BAC.N) Merrill Lynch unit must pay more than $15.2 million to thousands of customers who bought Class C mutual fund shares when Class A shares were available at substantially lower costs, a U.S. regulator said on Thursday. read more »

Caris Life Sciences Pays over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests


Caris Life Sciences, Inc. (Caris) has agreed to pay $2,886,674.86 to resolve allegations that it violated the False Claims Act in an alleged nationwide scheme to improperly bill Medicare for laboratory tests known as “Caris Molecular Intelligence” and the “ADAPT Biotargeting System.” read more »